
Ovid Therapeutics Inc. 2025 This autumn – Results – Earnings Call Presentation (NASDAQ:OVID) 2026-03-19
Q4: 2026-03-18 Earnings Summary EPS of $0.06 beats by $0.16 | Revenue of $718.00K (844.74% Y/Y) beats by $655.40K This article…

Q4: 2026-03-18 Earnings Summary EPS of $0.06 beats by $0.16 | Revenue of $718.00K (844.74% Y/Y) beats by $655.40K This article…

For decades, the standard formula for financial success was the same: go to college, get a degree, and land a…

Justine Iverson Hello, everyone, and welcome to today’s webinar. My name is Justine Iverson, and I look after the Corporate…

This article was written by Follow Over fifteen years of experience making contrarian bets based on my macro view and…

This article was written by Follow I’m a full-time investor with a strong focus on the tech sector. I graduated…

This article was written by Follow I’ve been researching companies in-depth for over a decade, from commodities like oil, natural…

This article was written by Follow I am mostly a trader engaging in both long and short bets intraday and…

The U.S.-Israeli war on Iran is already lost for the United States. Even if Iran is militarily defeated, it is…

Micron Just Smashed Estimates – Buy The Dip

College Republicans have sued the University of Florida’s president on free speech grounds over the school’s decision to deactivate its…
Get the latest tech, social media, politics, business, sports and many more news directly to your inbox.